Schizophrenia is best understood not as a single neurotransmitter disorder but as a convergence syndrome in which genetic vulnerability, aberrant synaptic pruning, NMDA hypofunction on parvalbumin-positive GABAergic interneurons, and dopaminergic salience dysregulation interact across neurodevelopment to produce its full clinical expression. The core phenomenological disturbance — ipseity, the pre-reflective sense of existing as the subject of one's own experience — is not adequately captured by any single neurochemical model alone and represents the true discriminatory feature of schizophrenia beyond its observable symptoms. Sitting strategically between all of these systems is the 5-HT2A receptor, densely expressed on the apical dendrites of Layer V pyramidal neurons in association cortices—the primary cortical output hub—where it functions not as a primary pathological agent but as a high-gain amplifier of already destabilized, temporally incoherent circuitry. This amplified, fragmented output then propagates to the thalamus, which fails to filter it and recursively loops it back to the cortex, and to the associative striatum, where dopamine assigns aberrant salience to an already incoherent signal—generating the positive symptoms and sustaining delusional states. The psychedelic parallel serves as an elegant proof of concept: 5-HT2A agonism on an intact circuit produces unity and perceptual richness, while the same gain amplification on a structurally destabilized circuit produces fragmentation, self-dissolution, and psychosis. Current pharmacotherapy — from typical antipsychotics through atypical agents to emerging treatments like cariprazine and xanomeline-trospium — can suppress downstream consequences of this architecture but cannot reconstruct the dendritic spines and network coherence lost to aberrant pruning. This structural ceiling means that the greatest therapeutic leverage for 5-HT2A modulation likely exists during the neurodevelopmental window itself, before architectural damage is consolidated, pointing toward earlier identification of vulnerability and circuit-level intervention as the genuinely necessary paradigm shift.